Chlorhexidine Acetate Topical Solution
DEFINITION
Chlorhexidine Acetate Topical Solution contains NLT 90.0% and NMT 110.0% of the labeled amount of chlorhexidine acetate (C22H30Cl2N10·2C2H4O2).
IDENTIFICATION
•  A. The retention time of the major peak for chlorhexidine from the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
•  B. Identification Tests—General, Acetate 191: Meets the requirements of the lanthanum nitrate test
Sample:  Evaporate or dilute a volume of Topical Solution containing the equivalent of about 5 mg of chlorhexidine acetate to about 5 mL.
ASSAY
•  Procedure
Solution A:  Dissolve 27.6 g of monobasic sodium phosphate and 10 mL of triethylamine in 1.5 L of water. Adjust with phosphoric acid to a pH of 3.0, and dilute with water to 2000 mL. Prepare a mixture of the resulting solution and acetonitrile (70:30).
Solution B:  Acetonitrile
Mobile phase:  See the gradient table below.
Time
(min)
Solution A
(%)
Solution B
(%)
0 100 0
9 100 0
10 45 55
15 45 55
16 100 0
21 100 0
System suitability solution:  50 µg/mL of USP Chlorhexidine Acetate RS and 1 µg/mL of USP p-Chloroaniline RS in Solution A
Standard solution:  40 µg/mL of USP Chlorhexidine Acetate RS in Solution A
Sample solution:  Nominally 40 µg/mL of chlorhexidine acetate from the Topical Solution, prepared as follows. Transfer an amount of Topical Solution, equivalent to 20 mg of chlorhexidine acetate, to a 100-mL volumetric flask, and dilute with methanol to volume. Further dilute a 10-mL portion of this solution with Solution A to 50 mL.
Chromatographic system 
Mode:  LC
Detector:  UV 239 nm
Column:  4.6-mm × 25-cm; 5-µm packing L1
Column temperature:  40
Flow rate:  1.5 mL/min
Injection size:  50 µL
System suitability 
Sample:  System suitability solution
[Note—The approximate relative retention times for chlorhexidine and p-chloroaniline are about 1.0 and 1.3, respectively. ]
Suitability requirements 
Resolution:  NLT 3.0 between chlorhexidine and p-chloroaniline
Relative standard deviation:  NMT 2.0% for the chlorhexidine peak, NMT 5.0% for the p-chloroaniline peak
Analysis 
Samples:  Standard solution and Sample solution
Calculate the percentage of C22H30Cl2N10·2C2H4O2 in the portion of Topical Solution taken:
Result = (rU/rS) × (CS/CU) × 100
rU== peak area of chlorhexidine from the Sample solution
rS== peak area of chlorhexidine from the Standard solution
CS== concentration of USP Chlorhexidine Acetate RS in the Standard solution (µg/mL)
CU== nominal concentration of chlorhexidine acetate in the Sample solution (µg/mL)
Acceptance criteria:  90.0%–110.0%
IMPURITIES
Organic Impurities 
•  Procedure: Limit of p-Chloroaniline
Solution A, Solution B, Mobile phase, System suitability solution, and Chromatographic system:  Proceed as directed in the Assay.
Standard solution:  1.0 µg/mL of USP p-Chloroaniline RS in Solution A
Sample solution:  Nominally 2.0 mg/mL of chlorhexidine acetate from the Topical Solution, prepared as follows. Transfer an amount of Topical Solution, equivalent to 200 mg of chlorhexidine acetate, to a 100-mL volumetric flask, and dilute with Solution A to volume.
Analysis 
Samples:  Standard solution and Sample solution
Acceptance criteria:  The p-chloroaniline peak area from the Sample solution is NMT the p-chloroaniline peak area from the Standard solution (NMT 500 ppm, calculated with reference to the nominal content of chlorhexidine acetate).
SPECIFIC TESTS
•  pH 791: 5.0–7.0
ADDITIONAL REQUIREMENTS
•  Packaging and Storage: Preserve in well-closed containers, protected from light.
•  Labeling: Label it to indicate that it is for veterinary use only.
•  USP Reference Standards 11
USP Chlorhexidine Acetate RS
USP p-Chloroaniline RS
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Morgan Puderbaugh, B.S.
Associate Scientific Liaison
1-301-998-6833
(SM32010) Monographs - Small Molecules 3
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
USP35–NF30 Page 2622
Pharmacopeial Forum: Volume No. 36(1) Page 87